AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹25,141 Cr | ₹23,159 Cr | ₹21,137 Cr | ₹19,071 Cr | ₹19,441 Cr |
What is the latest Total Expenditure of AUROBINDO PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹25,141 Cr |
| Mar2024 | ₹23,159 Cr |
| Mar2023 | ₹21,137 Cr |
| Mar2022 | ₹19,071 Cr |
| Mar2021 | ₹19,441 Cr |
How is Total Expenditure of AUROBINDO PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹25,141 Cr | 8.56 | |
| Mar2024 | ₹23,159 Cr | 9.57 | |
| Mar2023 | ₹21,137 Cr | 10.83 | |
| Mar2022 | ₹19,071 Cr | -1.90 | |
| Mar2021 | ₹19,441 Cr | - | |
Compare Total Expenditure of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹79,889.0 Cr | 3% | 5.4% | 22.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -1% | -7% | -1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 5% | -2.7% | 15.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -6.2% | 29.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 2.3% | -8.1% | 13.5% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.9% | -7.8% | -12.5% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 3% |
5.4% |
22.3% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses